Clinical Trials Directory

Trials / Completed

CompletedNCT00914550

Use Of Procalcitonin Level For Guidance of The Treatment of Suspected Community Acquired Pneumonia

Status
Completed
Phase
Study type
Observational
Enrollment
47 (actual)
Sponsor
Winthrop University Hospital · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of the study is to learn if a blood test is helpful to the doctors in deciding whether you need antibiotic therapy for possible pneumonia. The blood test is called a Procalcitonin level and sometimes the test reflects infection with certain bacteria (germs). When the doctors learn the results of these blood tests, they may be able to stop some of the antibiotic medications that they may have given to the patients. The study is designed, so that on a randomized basis (50/50 chance) the results from measuring Procalcitonin will be given to the patients' doctor. When the doctor receives these results, he/she may use this information, along with other information, to decide whether to continue antibiotic therapy.

Detailed description

To evaluate the usefulness of serum Procalcitonin level measured to guide the antibiotic treatment of patients with radiographic lung infiltrates.The subjects involved in the study will be divided in two arms ,study arm where the caregivers will know the result of Procalcitonin level and they can change /withheld the antibiotic for the subjects.In other arm only investigators will know the Procalcitonin level. We expect to enroll 100 patients.

Conditions

Interventions

TypeNameDescription
OTHERProcalcitonin level, caregiver informedProcalcitonin levels will be measured and known by investigator, only 1/2 of the patients' caregivers will know the results of serial Procalcitonin levels. We will analyze the rate of antibiotic discontinuation for the two arms

Timeline

Start date
2009-06-01
Primary completion
2012-09-01
Completion
2012-09-01
First posted
2009-06-05
Last updated
2014-12-15

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00914550. Inclusion in this directory is not an endorsement.

Use Of Procalcitonin Level For Guidance of The Treatment of Suspected Community Acquired Pneumonia (NCT00914550) · Clinical Trials Directory